Spending estimates for gastric cancer in central Brazil
Nenhuma Miniatura disponível
Data
2022
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Stomach cancer is the second leading cause of death by cancer worldwide and is even more
pronounced in South America. In Brazil, it is estimated that an increase in the number of
cases due to this cancer occurred in the biennium 2018-2019. In this study, we investigated
the expenditures of the State Health Department of Goiás on hospitalizations and treatment of
gastric cancer for the Unified Health System (SUS) from 2008-2016. This is a cross-sectional,
descriptive, and analytical study based on secondary data from the Unified Health System
computing department (DATASUS) and the System of Management of the Table of Procedures,
Medications, Orthosis, Prosthesis, and Special Materials of SUS through CONECTA-SUS
related to International Classification of Diseases-10/C16 (ICD-10/C16) procedures for gastric
neoplasms. A total of I$ 5,697,958.20 was spent on gastric tumor in the last nine years in
Goiás, I$ 4,492,916.67 (0.3%) on hospitalizations, and I$ 1,997,120.91 on treatment. This
study presents a current and relevant estimate of the costs of gastric cancer patients in Goiás.
Moreover, we provide information on the extent of the cancer issue to public health. Our
analysis offers components for service management and studies that reduce resource allocation
in more rational ways.
Descrição
Palavras-chave
Gastric neoplasms, Treatment, Spending, Cost, Cost analysis
Citação
PONTES, Jaqueline Correia et al. Spending estimates for gastric cancer in central Brazil. Brazilian Journal of Pharmaceutical Sciences, São Paulo, v. 58, e181069, 2022. DOI: 10.1590/s2175-97902022e181069. Disponível em: https://revistas.usp.br/bjps/article/view/204493. Acesso em: 3 jun. 2025.